An van Den Eeden

An Van den Eeden has a diverse work experience spanning over several companies and roles. An is currently employed at Novavax as the Senior Director of European Compliance, a position they started in 2023. Prior to this, they worked at Global Blood Therapeutics, a Pfizer company, where they held the role of Compliance Lead for Europe and GCC from 2022 to 2023. An also had a transition role at Pfizer during this time. Before that, An Van den Eeden worked at bluebird bio as the Senior Director and later as the Director of Head of Compliance and Ethics for Europe and Expansion. An was responsible for building a strategic compliance program and enhancing a culture of ethical collaboration from 2019 to 2021. In their earlier years, they held positions at Takeda and Shire in the field of ethics and compliance. An also gained experience in compliance and legal management at Medtronic International Trading SARL, Chiquita, Komatsu Europe Coordination Center NV, and Deloitte & Touche. An Van den Eeden has a strong background in compliance and ethics, with a focus on healthcare and international markets.

An Van den Eeden attended the University of Antwerp from 1989 to 1991, where they studied Law. In 1991, they enrolled at AP Hogeschool Antwerpen and completed a degree in Management in Business Practice and Law Practice, focusing on business law, corporate law, and European law. In 2012, they attended Seton Hall University School of Law for the Healthcare Compliance Ethics and Regulations Program, specializing in Bioethics/Medical Ethics. Additionally, they completed an influencing skills course but no specific start or end years are provided for this training. An Van den Eeden also attended Atheneum Berchem, although no degree or field of study is provided for this institution.